U.S.-based Solar Biotech acquires future Cleantech Commons tenant, Noblegen: confirms commitment to R&D facility at research park
Following the acquisition, new company Solar Biotech Canada confirms that it is committed to locating its GEN2 R&D facility at the Cleantech Commons research park – with a focus on transforming consumer goods to ensure a sustainable future Solar Biotech, a U.S. developer and…